Tech Company Financing Transactions

Dimension Therapeutics Funding Round

Dimension Therapeutics, operating out of Cambridge, scored $5 million from F-Prime Capital and private investors.

Transaction Overview

Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors

F-Prime Capital (Benjamin Auspitz)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Drive
Cambridge, MA 02139
USA
Email Address
Overview
Dimension Therapeutics, Inc., is a leading rare disease company focused on developing novel treatments for devastating disorders associated with the liver and based on an industry-leading, extensively validated adeno-associated virus (AAV) platform.
Profile
Dimension Therapeutics LinkedIn Company Profile
Social Media
Dimension Therapeutics Company Twitter Account
Company News
Dimension Therapeutics News
Facebook
Dimension Therapeutics on Facebook
YouTube
Dimension Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Annalisa Jenkins
  Annalisa Jenkins LinkedIn Profile  Annalisa Jenkins Twitter Account  Annalisa Jenkins News  Annalisa Jenkins on Facebook
Chief Financial Officer
Jean Franchi
  Jean Franchi LinkedIn Profile  Jean Franchi Twitter Account  Jean Franchi News  Jean Franchi on Facebook
Chief Medical Officer
Eric Crombez
  Eric Crombez LinkedIn Profile  Eric Crombez Twitter Account  Eric Crombez News  Eric Crombez on Facebook
Chief Scientific Officer
Sam Wadsworth
  Sam Wadsworth LinkedIn Profile  Sam Wadsworth Twitter Account  Sam Wadsworth News  Sam Wadsworth on Facebook
VP - Bus. Development
Andy Hu
  Andy Hu LinkedIn Profile  Andy Hu Twitter Account  Andy Hu News  Andy Hu on Facebook
VP - Human Resources
Rachel Strauss
  Rachel Strauss LinkedIn Profile  Rachel Strauss Twitter Account  Rachel Strauss News  Rachel Strauss on Facebook
VP - Manufacturing
Reed Clark
  Reed Clark LinkedIn Profile  Reed Clark Twitter Account  Reed Clark News  Reed Clark on Facebook
VP - Operations
Stephanie Haller
  Stephanie Haller LinkedIn Profile  Stephanie Haller Twitter Account  Stephanie Haller News  Stephanie Haller on Facebook
VP - Regulatory Affairs
Khandan Baradaran
  Khandan Baradaran LinkedIn Profile  Khandan Baradaran Twitter Account  Khandan Baradaran News  Khandan Baradaran on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2013: Molecule Software venture capital transaction
Next: 12/31/2013: Appthority venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary